Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024

エキソソーム研究関連製品の世界市場予測(~2024年)

◆タイトル:Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024
◆商品コード:BT 6939
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年2月28日
◆ページ数:128
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオテクノロジー
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥621,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

エキソソーム研究関連製品の世界市場は、2019年の9,100万米ドルから2024年には2億6,400万米ドルに達し、この期間中23.8%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、ライフサイエンス研究への資金提供の増加、がんの蔓延、およびエキソソームベースの治療への関心の高まりなどが考えられます。一方で、熟練した専門家の不足により、この市場の成長は抑制される可能性があります。当調査レポートでは、エキソソーム研究関連製品の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品・サービス(キット、試薬、機器、サービス)分析、用途(がん)分析、エンドユーザー(病院、学術機関、研究所)分析、エキソソーム研究関連製品の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“High global prevalence of cancer and increasing funding for life sciences are expected to drive the overall growth of the exosome research products market”The global exosome research products market is projected to reach USD 264 million by 2024 from USD 91 million in 2019, at a CAGR of 23.8% during the forecast period. Factors driving the growth of this market include the increasing funding for life science research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. However, the dearth of skilled professionals is a major factor that is expected to restrain the growth of this market to a certain extent in the coming years.

“The pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR during the forecast period”
Based on end user, the exosomes research products market is segmented into academic & research institutes, hospitals & clinical testing laboratories, and pharmaceutical & biotechnology companies. Pharmaceutical & biotechnology companies are expected to grow at a higher CAGR during the forecast period. This can majorly be attributed to significant investments by companies in research activities for the development of exosome-based diagnostics to combat new diseases.

“The lung cancer segment accounted for the largest share of the exosome research products market during the forecast period”
Based on cancer applications, the exosomes research products market is segmented into lung, prostate, breast, colorectal, and other cancers. In 2018, lung cancer accounted for the largest share of the exosomes market for cancer applications. The large share of this segment can primarily be attributed to factors such as the increasing prevalence of lung cancer, technological advancements in instruments & assays for liquid biopsy, and the growing demand for advanced diagnostic technologies.

“North America to dominate the market during the forecast period”
In 2018, North America accounted for the largest share of the exosome research products market. The North American market is also expected to grow at the highest CAGR during the forecast period. Factors such as the availability of government funding for life science research, favorable regulatory environment, increasing focus on exosomes in research and diagnostics, and the presence of high-quality infrastructure for clinical and laboratory research are driving the growth of the exosomes market in North America. According to R&D Magazine (2018), North America accounted for 27.36% of global R&D spending. North America has several national institutes that support biotechnology and life science research activities. The growth of the biotechnology and pharmaceutical industries and growth in the number of cancer cases in the region are also supporting market growth.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 (55%), Tier 2 (20%), and Tier 3 (25%)
• By Designation: C-level (58%), D-level (19%), and Others (23%)
• By Region: North America (40%), Europe (30%), Asia (10%), and RoW (20%)

List of Companies Profiled in the Report
• Thermo Fisher Scientific (US)
• QIAGEN N.V. (Netherlands)
• Lonza (Switzerland)
• Bio-Techne (US)
• System Biosciences, LLC. (US)
• NX Pharmagen (US)
• Miltenyi Biotec (Germany)
• AMS Biotechnology (Europe) Limited (UK)
• NanoSomiX (US)
• Norgen Biotek Corp. (Canada)

Research Coverage:
This report provides a detailed picture of the global exosome research products market. It aims at estimating the size and future growth potential of the market across different segments, such as product & service, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall exosome research products market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKET COVERED 15
1.3.2 YEARS CONSIDERED FOR THE STUDY 16
1.4 CURRENCY 16
1.5 LIMITATIONS 16
1.6 STAKEHOLDERS 17
2 RESEARCH METHODOLOGY 18
2.1 RESEARCH DATA 18
2.1.1 SECONDARY DATA 19
2.1.1.1 Key data from secondary sources 19
2.1.2 PRIMARY DATA 20
2.1.2.1 Key data from primary sources 20
2.2 MARKET SIZE ESTIMATION 21
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.4 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 29
4.1 EXOSOMES MARKET: OVERVIEW 29
4.2 EXOSOMES MARKET, BY APPLICATION, 2019–2024 (USD MILLION) 30
4.3 EXOSOME MARKET SHARE, BY CANCER APPLICATIONS & REGION (2018) 31
4.4 EXOSOME MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 32
4.5 EXOSOME MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 32
5 MARKET OVERVIEW 33
5.1 INTRODUCTION 33
5.2 MARKET DYNAMICS 33
5.2.1 DRIVERS 34
5.2.1.1 Increasing funding for life sciences research 34
5.2.1.2 High global prevalence of cancer 34
5.2.1.3 Increasing interest in exosome-based procedures 35
5.2.2 RESTRAINTS 36
5.2.2.1 Lack of skilled professionals 36

5.2.3 OPPORTUNITIES 36
5.2.3.1 Untapped emerging markets 36
5.2.3.2 Growing interest in exosome-based therapeutics 37
5.2.3.3 Personalized medicine 37
6 EXOSOMES MARKET, BY PRODUCT & SERVICE 38
6.1 INTRODUCTION 39
6.2 KITS AND REAGENTS 40
6.2.1 KITS AND REAGENTS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE EXOSOMES MARKET DURING THE FORECAST PERIOD 40
6.3 INSTRUMENTS 41
6.3.1 INCREASE IN THE NUMBER OF DIAGNOSTIC LABORATORIES OFFERING EXOSOME-BASED TESTS TO DRIVE THE ADOPTION OF INSTRUMENTS 41
6.4 SERVICES 42
6.4.1 EXOSOME SERVICES AID ONCOLOGISTS TO DETECT AND MONITOR CANCER BIOMARKERS FROM A SIMPLE BLOOD OR URINE SAMPLE 42
7 EXOSOMES MARKET, BY APPLICATION 43
7.1 INTRODUCTION 44
7.2 CANCER APPLICATIONS 45
7.2.1 LUNG CANCER 46
7.2.1.1 Increasing prevalence of lung cancer and technological advancements in instruments & assays for liquid biopsy to drive market growth 46
7.2.2 BREAST CANCER 47
7.2.2.1 High prevalence of breast cancer and increasing awareness to drive the market for this segment 47
7.2.3 PROSTATE CANCER 48
7.2.3.1 Liquid biopsy helps detect aggressive prostate cancer before surgery—a key factor driving market growth 48
7.2.4 COLORECTAL CANCER 49
7.2.4.1 Increasing research activities and projects based on exosomes to drive the market for this segment 49
7.2.5 OTHER CANCERS 50
7.2.5.1 Rising incidence of cancer and increasing research funding to drive the market for this segment 50
7.3 NON-CANCER APPLICATIONS 51
7.3.1 WIDE RANGE OF NON-CANCER APPLICATIONS TO DRIVE GROWTH IN THE DEMAND FOR EXOSOMES IN THIS APPLICATION SEGMENT 51

8 EXOSOMES MARKET, BY END USER 53
8.1 INTRODUCTION 54
8.2 ACADEMIC & RESEARCH INSTITUTES 55
8.2.1 ACADEMIC & RESEARCH INSTITUTES ARE THE LARGEST END USERS IN THE EXOSOMES MARKET 55
8.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 56
8.3.1 SIGNIFICANT DEVELOPMENTS IN RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH IN THIS END-USER SEGMENT 56
8.4 HOSPITALS & CLINICAL TESTING LABORATORIES 57
8.4.1 HOSPITALS & CLINICAL TESTING LABORATORIES USE EXOSOMES FOR THE DIAGNOSIS OF CANCER 57
9 EXOSOMES MARKET, BY REGION 58
9.1 INTRODUCTION 59
9.2 NORTH AMERICA 60
9.2.1 US 63
9.2.1.1 High burden of cancer and favorable public and private funding for research activities to drive market growth 63
9.2.2 CANADA 66
9.2.2.1 Availability of research funding & rising incidence of cancer to drive market growth 66
9.3 EUROPE 69
9.3.1 GERMANY 72
9.3.1.1 Presence of a large number of academic research institutes to support market growth 72
9.3.2 UK 74
9.3.2.1 Growth in the life sciences industry to drive the market for exosomes in the UK 74
9.3.3 FRANCE 77
9.3.3.1 Government initiatives to boost R&D activities in the country and high healthcare expenditure are the key factors driving market growth 77
9.3.4 ROE 79
9.4 ASIA 82
9.4.1 CHINA 85
9.4.1.1 Government initiatives to strengthen the biotechnology industry and the high prevalence of cancer are the major factors driving market growth 85
9.4.2 JAPAN 87
9.4.2.1 High prevalence of cancer and increasing healthcare expenditure are the key drivers for the exosomes market in the country 87
9.4.3 REST OF ASIA 89
9.5 REST OF THE WORLD 92

10 COMPETITIVE LANDSCAPE 96
10.1 OVERVIEW 96
10.2 MARKET SHARE ANALYSIS 97
10.3 COMPETITIVE SCENARIO 98
10.3.1 PARTNERSHIPS AND AGREEMENTS (2016–2019) 98
10.3.2 PRODUCT LAUNCHES (2016–2019) 99
10.3.3 ACQUISITIONS (2016–2019) 99
10.3.4 EXPANSIONS (2016–2019) 99
10.4 COMPETITIVE LEADERSHIP MAPPING (2017) 100
10.4.1 VANGUARDS 100
10.4.2 INNOVATORS 100
10.4.3 DYNAMIC PLAYERS 100
10.4.4 EMERGING PLAYERS 101
11 COMPANY PROFILES 102
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 BIO-TECHNE 102
11.2 THERMO FISHER SCIENTIFIC INC. 105
11.3 SYSTEM BIOSCIENCES (SBI) 108
11.4 NX PHARMAGEN 109
11.5 QIAGEN N.V. 110
11.6 MILTENYI BIOTECH 113
11.7 AMS BIOTECHNOLOGY LTD. 114
11.8 NANOSOMIX 115
11.9 LONZA GROUP AG 116
11.10 NORGEN BIOTEK CORP. 119

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX 120
12.1 INSIGHTS OF INDUSTRY EXPERTS 120
12.2 DISCUSSION GUIDE 121
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 124
12.4 AVAILABLE CUSTOMIZATIONS 126
12.5 RELATED REPORTS 126
12.6 AUTHOR DETAILS 127

LIST OF TABLES

TABLE 1 GLOBAL CANCER INCIDENCE, 2018 VS. 2025 34
TABLE 2 EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 39
TABLE 3 EXOSOMES MARKET FOR KITS AND REAGENTS, BY REGION,
2017–2024 (USD MILLION) 40
TABLE 4 EXOSOMES MARKET FOR INSTRUMENTS, BY REGION, 2017–2024 (USD MILLION) 41
TABLE 5 EXOSOMES MARKET FOR SERVICES, BY REGION, 2017–2024 (USD MILLION) 42
TABLE 6 EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 44
TABLE 7 EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE,
2017–2024 (USD MILLION) 45
TABLE 8 EXOSOMES MARKET FOR CANCER APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 46
TABLE 9 EXOSOMES MARKET FOR LUNG CANCER APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 47
TABLE 10 EXOSOMES MARKET FOR BREAST CANCER APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 48
TABLE 11 EXOSOMES MARKET FOR PROSTATE CANCER APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 49
TABLE 12 EXOSOMES MARKET FOR COLORECTAL CANCER APPLICATIONS, BY REGION, 2017–2024 (USD MILLION) 50
TABLE 13 EXOSOMES MARKET FOR OTHER CANCER APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 51
TABLE 14 EXOSOMES MARKET FOR NON-CANCER APPLICATIONS, BY REGION,
2017–2024 (USD MILLION) 52
TABLE 15 EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 54
TABLE 16 EXOSOMES MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION,
2017–2024 (USD MILLION) 55
TABLE 17 EXOSOMES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES,
BY REGION, 2017–2024 (USD MILLION) 56
TABLE 18 EXOSOMES MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES,
BY REGION, 2017–2024 (USD MILLION) 57
TABLE 19 EXOSOMES MARKET, BY REGION, 2017–2024 (USD MILLION) 59
TABLE 20 NORTH AMERICA: EXOSOMES MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 61
TABLE 21 NORTH AMERICA: EXOSOMES MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 61
TABLE 22 NORTH AMERICA: EXOSOMES MARKET, BY APPLICATION,
2017–2024 (USD MILLION) 61
TABLE 23 NORTH AMERICA: EXOSOMES MARKET FOR CANCER APPLICATIONS,
BY TYPE, 2017–2024 (USD MILLION) 62
TABLE 24 NORTH AMERICA: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 62
TABLE 25 US: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 64
TABLE 26 US: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 65
TABLE 27 US: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE,
2017–2024 (USD MILLION) 65
TABLE 28 US: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 65
TABLE 29 CANADA: EXOSOMES MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 67
TABLE 30 CANADA: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 68
TABLE 31 CANADA: EXOSOMES MARKET FOR CANCER APPLICATIONS,
BY TYPE, 2017–2024 (USD MILLION) 68
TABLE 32 CANADA: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 68
TABLE 33 EUROPE: EXOSOMES MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 70
TABLE 34 EUROPE: EXOSOMES MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 70
TABLE 35 EUROPE: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 70
TABLE 36 EUROPE: EXOSOMES MARKET FOR CANCER APPLICATIONS,
BY TYPE, 2017–2024 (USD MILLION) 71
TABLE 37 EUROPE: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 71
TABLE 38 GERMANY: EXOSOMES MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 72
TABLE 39 GERMANY: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 73
TABLE 40 GERMANY: EXOSOMES MARKET FOR CANCER APPLICATIONS,
BY TYPE, 2017–2024 (USD MILLION) 73
TABLE 41 GERMANY: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 74
TABLE 42 UK: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 75
TABLE 43 UK: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 75
TABLE 44 UK: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE,
2017–2024 (USD MILLION) 76
TABLE 45 UK: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 76
TABLE 46 FRANCE: EXOSOMES MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION) 77
TABLE 47 FRANCE: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 78
TABLE 48 FRANCE: EXOSOMES MARKET FOR CANCER APPLICATIONS,
BY TYPE, 2017–2024 (USD MILLION) 78
TABLE 49 FRANCE: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 79
TABLE 50 ROE: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 80
TABLE 51 ROE: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 80
TABLE 52 ROE: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE,
2017–2024 (USD MILLION) 81
TABLE 53 ROE: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 81
TABLE 54 ASIA: EXOSOMES MARKET, BY COUNTRY, 2017–2024 (USD MILLION) 83
TABLE 55 ASIA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 83
TABLE 56 ASIA: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 83
TABLE 57 ASIA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE,
2017–2024 (USD MILLION) 84
TABLE 58 ASIA: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 84
TABLE 59 CHINA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 85
TABLE 60 CHINA: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 86
TABLE 61 CHINA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE,
2017–2024 (USD MILLION) 86
TABLE 62 CHINA: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 87
TABLE 63 JAPAN: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 88
TABLE 64 JAPAN: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 88
TABLE 65 JAPAN: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE,
2017–2024 (USD MILLION) 88
TABLE 66 JAPAN: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 89
TABLE 67 ROA: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 90
TABLE 68 ROA: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 90
TABLE 69 ROA: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE,
2017–2024 (USD MILLION) 91
TABLE 70 ROA: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 91
TABLE 71 ROW: EXOSOMES MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION) 94
TABLE 72 ROW: EXOSOMES MARKET, BY APPLICATION, 2017–2024 (USD MILLION) 94
TABLE 73 ROW: EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE,
2017–2024 (USD MILLION) 94
TABLE 74 ROW: EXOSOMES MARKET, BY END USER, 2017–2024 (USD MILLION) 95


LIST OF FIGURES

FIGURE 1 EXOSOMES MARKET SEGMENTATION 15
FIGURE 2 RESEARCH DESIGN 18
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 21
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 22
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 22
FIGURE 6 DATA TRIANGULATION METHODOLOGY 23
FIGURE 7 EXOSOMES MARKET, BY PRODUCT & SERVICE, 2019 VS. 2024 (USD MILLION) 25
FIGURE 8 EXOSOMES MARKET, BY APPLICATION, 2019 (USD MILLION) 26
FIGURE 9 EXOSOMES MARKET FOR CANCER APPLICATIONS, BY TYPE,
2019 VS. 2024 (USD MILLION) 26
FIGURE 10 EXOSOMES MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 27
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE EXOSOMES MARKET 28
FIGURE 12 HIGH GLOBAL BURDEN OF CANCER & INCREASING FUNDING FOR LIFE SCIENCE RESEARCH ARE DRIVING THE GROWTH OF THE EXOSOME MARKET 29
FIGURE 13 NON-CANCER APPLICATION SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 30
FIGURE 14 LUNG CANCER SEGMENT TO ACCOUNT FOR THE LARGEST MARKET
SHARE IN 2018 31
FIGURE 15 ACADEMIC & RESEARCH INSTITUTES TO HOLD THE LARGEST SHARE OF THE EXOSOME MARKET DURING THE FORECAST PERIOD 32
FIGURE 16 NORTH AMERICA IS THE FASTEST-GROWING REGION IN THE EXOSOME MARKET 32
FIGURE 17 EXOSOMES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 33
FIGURE 18 KITS AND REAGENTS SEGMENT WILL CONTINUE TO DOMINATE THE EXOSOME PRODUCTS MARKET DURING THE FORECAST PERIOD 39
FIGURE 19 CANCER APPLICATIONS SEGMENT TO DOMINATE EXOSOMES MARKET DURING THE FORECAST PERIOD (2019–2024) 44
FIGURE 20 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 54
FIGURE 21 NORTH AMERICA: EXOSOMES MARKET SNAPSHOT 60
FIGURE 22 US: CANCER STATISTICS 63
FIGURE 23 CANADA: CANCER STATISTICS 67
FIGURE 24 EUROPE: EXOSOMES MARKET SNAPSHOT 69
FIGURE 25 ASIA: EXOSOMES MARKET SNAPSHOT 82
FIGURE 26 ROW: EXOSOMES MARKET SNAPSHOT 93
FIGURE 27 KEY DEVELOPMENTS IN THE EXOSOMES MARKET (JAN 2016-JAN 2019) 96
FIGURE 28 MARKET EVOLUTION FRAMEWORK 97
FIGURE 29 EXOSOMES MARKET RANKING ANALYSIS, BY KEY PLAYER (2017) 97
FIGURE 30 MNM DIVE-VENDOR COMPARISON MATRIX: EXOSOMES MARKET 101
FIGURE 31 COMPANY SNAPSHOT: BIO-TECHNE 102
FIGURE 32 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC 105
FIGURE 33 COMPANY SNAPSHOT: QIAGEN N.V. 110
FIGURE 34 LONZA GROUP AG: COMPANY SNAPSHOT 116


★調査レポート[エキソソーム研究関連製品の世界市場予測(~2024年)] ( Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024 / BT 6939) 販売に関する免責事項
[エキソソーム研究関連製品の世界市場予測(~2024年)] ( Exosome Research Products Market by Product and Services (Kit, Reagent, Instrument, Service), Application (cancer [lung cancer, prostate cancer, breast cancer]), and End User (Hospitals, Academics, Research Institute) - Global Forecast to 2024 / BT 6939) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆